Sign Up
Stories
Advancements in Antibodies to Protect Immunocompromised Patients Against COVID-19
Share
Biosimilar Breakthrough: Simlandi FDA Ap...
COVID-19 Research Advances
Health Concerns: COVID-19, Bird Flu, and...
AI-Powered Antigen Research Partnership
Advancements in Medical Trials
BioNTech's mRNA Cancer Vaccine Progress
Overview
API
AstraZeneca and Aerium Therapeutics make progress in developing antibodies to protect immunocompromised individuals against COVID-19. Federal focus on monoclonal antibodies (mAbs) as anti-virus tools is discussed, along with the need for expanded treatment options.
Ask a question
How can healthcare systems optimize immune protection for patients?
What are the challenges in expanding treatment options for immunocompromised individuals?
What are the potential benefits and drawbacks of using mAbs as anti-virus tools?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jun 2023
Jul 2023
Aug 2023
Sep 2023
Oct 2023
Coverage